Form 4: Beauty Health CEO Granted Over 2.6M RSUs

Pedro Bruno Ferreira Malha, President and CEO of The Beauty Health Company, received a grant of 2,654,867 restricted stock units.

Summary

• Pedro Bruno Ferreira Malha, President and CEO, Director, and 10% Owner of The Beauty Health Company (SKIN), was granted 2,654,867 Restricted Stock Units (RSUs).
• The transaction date for this grant was March 20, 2026.
• Following this transaction, Malha beneficially owns 4,845,251 shares of Class A Common Stock.
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs are subject to time-vesting conditions, vesting in one-third increments on each of the first three anniversaries of the grant date (March 20, 2026).
• Vesting is contingent upon continued service with the Company through the vesting date, with certain acceleration rights.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it strengthens the alignment between the CEO's interests and long-term shareholder value, although it introduces potential future dilution.

Positives

• The grant of 2,654,867 Restricted Stock Units to the President and CEO aligns management's interests with long-term shareholder value.
• The vesting schedule over three years encourages sustained leadership and performance.

Negatives

• The grant of new RSUs could lead to potential future dilution for existing shareholders as the units vest into common stock.

Risks

• The vesting of the RSUs is subject to Pedro Bruno Ferreira Malha's continued service with The Beauty Health Company through the vesting dates.
• Failure to meet service conditions would result in forfeiture of unvested RSUs.

Future Outlook

The vesting schedule of the RSUs over the next three years indicates a commitment from the CEO to the company's long-term performance and continued service.

Industry Context

StockSavvy.ai notes that equity grants, particularly Restricted Stock Units, are a standard component of executive compensation packages across various industries. They are designed to align the interests of executives with those of shareholders by tying a significant portion of their compensation to the company's stock performance and their continued tenure. This grant to The Beauty Health Company's President and CEO is consistent with common practices for retaining and incentivizing top leadership.

Comparison to Industry Standards

• Executive compensation structures, including RSU grants, vary widely by industry, company size, and performance.
• While the specific number of RSUs granted to Pedro Bruno Ferreira Malha is substantial, it is within the typical range for CEOs of publicly traded companies of similar market capitalization to The Beauty Health Company, aiming to provide competitive incentives.
• For instance, comparable grants might be seen at companies like e.l.f. Beauty (ELF) or Olaplex Holdings (OLPX) for their top executives, though specific numbers would depend on individual performance, company size, and compensation committee decisions.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through aligned management incentives; potential for future dilution as RSUs convert to shares.
• Employees: May signal stability in leadership and a commitment to long-term company strategy.

Next Steps

• Pedro Bruno Ferreira Malha's continued service with The Beauty Health Company through the vesting dates.
• Vesting of one-third of the RSUs on March 20, 2027, March 20, 2028, and March 20, 2029.

Key Dates

Keywords

Beauty Health Company, SKIN, Pedro Bruno Ferreira Malha, Restricted Stock Units, RSU grant, insider transaction, executive compensation, Form 4, equity award, vesting